登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式(希尔记法):
C25H19N5S
化学文摘社编号:
分子量:
421.52
MDL number:
UNSPSC Code:
12352200
NACRES:
NA.54
Assay:
≥97% (HPLC)
Form:
solid
Quality level:
Storage condition:
OK to freeze, protect from light
产品名称
TGF-β RI 激酶抑制剂 IV, TGF-β RI Kinase Inhibitor IV, CAS 909910-43-6, is a cell-permeable, selective inhibitor of ALK-4/5/7-mediated signaling (IC50 = 45, 12, and 7.5 nM, respectively).
Quality Level
assay
≥97% (HPLC)
form
solid
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, protect from light
color
pale yellow
solubility
DMSO: 20 mg/mL
shipped in
ambient
storage temp.
2-8°C
SMILES string
S=C([n]2nc(c(c2)c4c5c(ncc4)cccc5)c3nc(ccc3)C)Nc1ccccc1
InChI
1S/C25H19N5S/c1-17-8-7-13-23(27-17)24-21(19-14-15-26-22-12-6-5-11-20(19)22)16-30(29-24)25(31)28-18-9-3-2-4-10-18/h2-16H,1H3,(H,28,31)
InChI key
HIJMSZGHKQPPJS-UHFFFAOYSA-N
General description
一种细胞渗透性三取代吡唑化合物,已显示在表达单个I型TGF-β受体的Mv1Lu R4-2转染子中选择性抑制ALK-4/5/7介导(荧光素酶转录活性测定中IC50分别为45、12和7.5 nM),但不抑制ALK-1/2/3/6介导的细胞信号。在浓度为1 µM的情况下,抑制HaCaT细胞中TGF-β-诱导的Smad2磷酸化和NMuMG细胞中的上皮间质转化。
Biochem/physiol Actions
主要靶标
ALK-4/5/7
ALK-4/5/7
产物不与ATP竞争。
可逆:否
细胞可渗透性:是
靶标IC50:抑制ALK-4/5/7介导的荧光素酶转录活性测定分别为45、12和7.5 nM
Packaging
用惰性气体包装
Preparation Note
复溶后,等分并冷冻保存(-20°C)。贮备溶液在-20°C下可稳定保存至多3个月。
Other Notes
Tojo, M., et al. 2005.Cancer Sci.96, 791.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
毒性:有害(C)
Still not finding the right product?
Explore all of our products under TGF-β RI 激酶抑制剂 IV
存储类别
11 - Combustible Solids
wgk
WGK 3
Felix Kretzschmar et al.
Biology, 10(12) (2021-12-25)
As resident innate immune cells of the CNS, microglia play important essential roles during physiological and pathological situations. Recent reports have described the expression of Lilrb4 in disease-associated and aged microglia. Here, we characterized the expression of Lilrb4 in microglia
Fabian Trillsch et al.
STAR protocols, 4(3), 102484-102484 (2023-08-16)
We present a protocol for effective biobanking of epithelial ovarian cancer organoids, considering the heterogeneous clinical presentation and high recurrence rates. Our protocol involves parallel testing of three media to identify patient-specific optimal conditions. We describe steps for tissue dissociation
Naveen Kumar et al.
Nature communications, 15(1), 3064-3064 (2024-04-10)
The gastroesophageal squamocolumnar junction (GE-SCJ) is a critical tissue interface between the esophagus and stomach, with significant relevance in the pathophysiology of gastrointestinal diseases. Despite this, the molecular mechanisms underlying GE-SCJ development remain unclear. Using single-cell transcriptomics, organoids, and spatial
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 616454-2MG | 04055977185867 |